KALA BIO Balance Sheet Health

Financial Health criteria checks 5/6

KALA BIO has a total shareholder equity of $7.5M and total debt of $34.2M, which brings its debt-to-equity ratio to 455.6%. Its total assets and total liabilities are $55.9M and $48.4M respectively.

Key information

455.6%

Debt to equity ratio

US$34.19m

Debt

Interest coverage ration/a
CashUS$50.90m
EquityUS$7.50m
Total liabilitiesUS$48.45m
Total assetsUS$55.95m

Recent financial health updates

Is Kala Pharmaceuticals (NASDAQ:KALA) Using Debt Sensibly?

Jul 07
Is Kala Pharmaceuticals (NASDAQ:KALA) Using Debt Sensibly?

Is Kala Pharmaceuticals (NASDAQ:KALA) Using Debt Sensibly?

Apr 05
Is Kala Pharmaceuticals (NASDAQ:KALA) Using Debt Sensibly?

Is Kala Pharmaceuticals (NASDAQ:KALA) Using Too Much Debt?

Dec 14
Is Kala Pharmaceuticals (NASDAQ:KALA) Using Too Much Debt?

Recent updates

Kala Pharmaceuticals to execute reverse stock split

Oct 20

Kala Pharmaceuticals Q2 2022 Earnings Preview

Aug 10

Staying Patient With Kala Pharmaceuticals

Aug 29

The Kala Pharmaceuticals, Inc. (NASDAQ:KALA) Analysts Have Been Trimming Their Sales Forecasts

Aug 10
The Kala Pharmaceuticals, Inc. (NASDAQ:KALA) Analysts Have Been Trimming Their Sales Forecasts

Is Kala Pharmaceuticals (NASDAQ:KALA) Using Debt Sensibly?

Jul 07
Is Kala Pharmaceuticals (NASDAQ:KALA) Using Debt Sensibly?

Is Kala Pharmaceuticals (NASDAQ:KALA) Using Debt Sensibly?

Apr 05
Is Kala Pharmaceuticals (NASDAQ:KALA) Using Debt Sensibly?

Kala Pharmaceuticals, Inc. (NASDAQ:KALA): When Will It Breakeven?

Mar 08
Kala Pharmaceuticals, Inc. (NASDAQ:KALA): When Will It Breakeven?

What Kind Of Investors Own Most Of Kala Pharmaceuticals, Inc. (NASDAQ:KALA)?

Feb 15
What Kind Of Investors Own Most Of Kala Pharmaceuticals, Inc. (NASDAQ:KALA)?

How Many Kala Pharmaceuticals, Inc. (NASDAQ:KALA) Shares Did Insiders Buy, In The Last Year?

Jan 25
How Many Kala Pharmaceuticals, Inc. (NASDAQ:KALA) Shares Did Insiders Buy, In The Last Year?

If You Had Bought Kala Pharmaceuticals (NASDAQ:KALA) Stock A Year Ago, You Could Pocket A 77% Gain Today

Jan 04
If You Had Bought Kala Pharmaceuticals (NASDAQ:KALA) Stock A Year Ago, You Could Pocket A 77% Gain Today

Kala Pharmaceuticals Should Have Limited Downside With Eysuvis Now Approved

Dec 23

The Play On Kala Pharmaceuticals

Dec 17

Is Kala Pharmaceuticals (NASDAQ:KALA) Using Too Much Debt?

Dec 14
Is Kala Pharmaceuticals (NASDAQ:KALA) Using Too Much Debt?

How Much Did Kala Pharmaceuticals' (NASDAQ:KALA) CEO Pocket Last Year?

Nov 26
How Much Did Kala Pharmaceuticals' (NASDAQ:KALA) CEO Pocket Last Year?

Financial Position Analysis

Short Term Liabilities: KALA's short term assets ($52.9M) exceed its short term liabilities ($8.3M).

Long Term Liabilities: KALA's short term assets ($52.9M) exceed its long term liabilities ($40.1M).


Debt to Equity History and Analysis

Debt Level: KALA has more cash than its total debt.

Reducing Debt: KALA's debt to equity ratio has increased from 66.9% to 455.6% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: KALA has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: KALA has sufficient cash runway for 1.2 years if free cash flow continues to reduce at historical rates of 3.4% each year.


Discover healthy companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.